MedTrace Logo

Food Trial to Evaluate the Safety and Tolerability of SBD111 in Health Adults

NCT05206864 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2022-04-13

No results posted yet for this study

Summary

The aim of the trial is to determine if the synbiotic (prebiotic and probiotic), provided twice daily (capsule) is safe and tolerable in healthy adults.

Conditions

  • Healthy

Interventions

OTHER

Medical Food: SBD111

One capsule administered twice daily with morning and evening meals for 28 days

OTHER

Placebo

One capsule administered twice daily with morning and evening meals for 28 days

Sponsors & Collaborators

  • Hebrew SeniorLife

    collaborator OTHER

  • Solarea Bio, Inc

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-01-05
Completion
2022-02-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05206864 on ClinicalTrials.gov